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Multiple Sclerosis (MS) is an immune-mediated process in which the body’s immune
system damages myelin in the central nervous system (CNS). The onset of this disorder
typically occurs in young adults, and it is more common amongwomen. Currently, there is
no cure and the long-term disease progression makes symptomatic management critical
for maintaining quality of life. Several pharmacotherapeutic agents are approved for
treatment, but many patients seek complementary and alternative interventions. Reviews
have been conducted regarding broad topics such as mindfulness-based interventions
for people diagnosed with MS and the impact of yoga on a range of neurological
disorders. The objective of the present review is to examine the potential benefits of
yoga for individuals with MS and address its use in managing symptoms including pain,
mental health, fatigue, spasticity, balance, bladder control, and sexual function.
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Introduction
Multiple Sclerosis (MS) was first recognized as a disease by the French neurologist Jean-Martin
Charcot in 1868. MS is a chronic neurological disorder in which the body’s immune systemmounts
an attack against the central nervous system (CNS). Within the CNS, oligodendrocytes produce the
fatty substance myelin, which wraps neuronal axons and allows for effective transmission of signals.
The T cell-mediated immune response associated withMS is directed toward oligodendrocytes and
myelin, producing a devastating effect. Demyelination is responsible for impaired neuronal con-
duction and the symptoms seen in patients with the disease. In addition to the inflammatory effect
on myelin, axonal injury occurs and is characterized by accumulation of amyloid precursor protein
(Bitsch et al., 2000). Common symptoms are varied and may include fatigue, spasticity, impair-
ment or loss of mobility, bladder and bowel dysfunction, chronic pain, depression, and cognitive
impairment (Senders et al., 2012; Ahmadi et al., 2013).
The onset of the disease typically occurs in young adults ages 20–40, and is far more prevalent
in females than in males. It is estimated that MS affects 400,000 people in the United States and
more than 2.5 million people worldwide. There are four courses categorizing this degenerative dis-
ease, which were initially described in 1996 by the National Multiple Sclerosis Society in the US. An
international panel later adopted these four courses in 2013. Of the four, relapse remitting (RRMS)
is the most common diagnosis. Over time, this typically progresses into a secondary progressive
(SPMS) course. The two less common forms ofMS are primary progressive (PPMS) and progressive
relapsing (PRMS) (Tullman, 2013). For patients with RRMS, onset of new symptoms occurs during
periods of relapse, which are followed by remission periods of varying lengths. In the majority of
these patients, RRMS develops into SPMS, and the disease progresses without periods of remission.
Individuals diagnosed with PPMS experience increasing neurologic dysfunction without periods
of remission from disease onset, and those with PRMS experience a steady decrease in neurologic
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function accompanied by occasional exacerbations and wors-
ening of symptoms. MS is not considered fatal and most peo-
ple have a near-normal life expectancy after diagnosis, although
there is tremendous variability in the rate of progression between
individuals.
Presently, there is no cure for MS. Therefore, the chronic
nature of the disease makes managing disease progression and
symptoms imperative for maintaining quality of life. There are
currently 12 disease-modifying medications approved by the U.S.
Food and Drug Administration (FDA) to reduce the severity of
relapses and the accumulation of brain lesions, though approved
MS medications may be expensive and insurance coverage varies
widely. These medications are designed for patients with relaps-
ing forms of MS, and no medications have been approved for
treatment of PPMS. Relapses are commonly treated with corti-
costeroids, which have no long-term benefits, and there is a wide
range of medications commonly used to manage ongoing symp-
toms. However, individuals may have adverse reactions to phar-
macological treatments. Somemedicationsmay produce negative
side effects such as nausea, fever, headache, fatigue, depression,
and psychological imbalance (Petejan et al., 1996; Ahmadi et al.,
2010). In response to the often-prohibitive costs of medications
and the adverse side effects that may accompany certain drugs,
patients with MS often use complementary and alternative treat-
ments as methods of disease management. It is estimated that
between 54 and 57% of patients in the United States with MS
use some form of complementary or alternative treatment, and
prevalence of these therapies may be even higher in other coun-
tries such as Great Britain (Hughes and Howard, 2013). Comple-
mentary and alternative medicine (CAM) includes a wide range
of non-pharmacological interventions that are defined by the
National Center for Complementary and Alternative Medicine
(NCCAM) as “complementary” when used in addition to con-
ventionalmedicine and “alternative” when used in place of it. Due
to the complex progression of MS, The National Society for MS
promotes a comprehensive approach for disease management,
including exercise and complementary therapies such as yoga.
Exercise was once believed to increase the fatigue and trou-
bles with becoming overheated that many MS patients experi-
ence, but is now acknowledged as an inexpensive and beneficial
form of therapy (Ahmadi et al., 2013). An exercise regimen com-
bining balancing, strengthening, stretching, and aerobic compo-
nents can be beneficial and enjoyable for individuals with MS
(Hale et al., 2003). Yoga is an ancient Indian practice that com-
bines these elements with a philosophy of mind-body awareness.
NCCAM defines yoga as a mind-body practice that incorporates
breathing, physical postures, and relaxation. There are many dif-
ferent forms of yoga with varying intensities, crossover between
practices, and diverse teaching styles. These practices include
Hatha and Kundalini, which are gentler and focus on breath and
poses; Iyengar, with a focus on poses and frequent use of props;
Ashtanga and Vinyasa, typically more physically demanding; and
Bikram yoga, taught in a heated setting (Senders et al., 2012).
Some of these practices are more appropriate than others for
people with MS, depending on the individual’s physical abilities.
Bikram yoga is likely to be hazardous for patients with MS due
to the heat sensitivity associated with the disease, while practices
incorporating props and cushions might be more appealing for
patients with neurodegenerative disorders such as MS (Wahbeh
et al., 2008).
Although effects on symptommanagement may vary between
individuals, yoga’s focus on breath, movement, and stretching
may have therapeutic benefits for patients with MS and improve
outcomes such as self-efficacy, mental health, and quality of life.
Viewed in this context, yoga is a promising method of symp-
tom management for patients with MS. Previous reviews have
addressed impact of yoga on a range of neurological disorders
(Mishra et al., 2012) andmindfulness-based interventions for MS
(Senders et al., 2012). The objective of the present article is to
examine the benefits of yoga for individuals with MS and address
its use in managing symptoms including pain, mental health,
fatigue, spasticity, balance, bladder control, and sexual function.
Yoga as an Intervention
Quality of life (QoL) is a broad concept, encompassing both
physical and mental health components. Pain is one physical
variable capable of affecting QoL, ability to work, and mental
health. Pain is a commonly reported symptom for individuals
with MS and manifestations include back pain, trigeminal neu-
ralgia, painful spasms, extremity pain, and headache (O’Connor
et al., 2008). Previous research has examined how pain and QoL
were impacted by a 3-month intervention of pain-managing
yoga techniques. In this clinical trial of 60 women with MS, the
treatment group reported significantly lower pain (p = 0.007)
and improved QoL (p = 0.001) following the intervention
(Doulatabad et al., 2013). Based on this study, pain-managing
yoga techniques enhanced QoL by decreasing pain in patience
with MS.
The mental health component of QoL includes depression,
cognition, stress, and mental fatigue. Depression, experienced by
up to 50% of patients with MS, can impact cognition, willing-
ness for treatment, and suicidal intent (Feinstein et al., 2013).
Results of an 8-week yoga intervention targeting depression
among women with MS, revealed significantly lower levels of
depression in the experimental group following the treatment
(n = 15, p < 0.05) and no change for the 15 participants in
the control group (Rhanama et al., 2011). Another study exam-
ined the impact of different forms of exercise on cognition in
24 patients with RRMS, found participants showed significantly
improved reaction time following treadmill walking, cycling, and
yoga compared to resting (Sandroff et al., 2015). Walking corre-
sponded to the sole significant reduction in the effect of interfer-
ing stimuli on reaction time (p = 0.04). However, participants
engaged in only 20min of each exercise, so these results may
not be applicable to a longer exercise regime. In a study of a
6-week relaxation-based yoga intervention on a sample of chron-
ically ill patients with cancer (n = 10) or MS (n = 12), both
groups of patients reported significantly lower perceived stress
(p < 0.001), with a greater effect for patients with MS (Pritchard
et al., 2010). In additional studies, researchers examined the effect
of an 8-week mindfulness-based intervention (MBI) using yoga
on depression, anxiety, and fatigue in participants with RRMS
or SPMS (Grossman et al., 2010). Participants who received the
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intervention (n = 76) showed improved levels of depression,
anxiety, and fatigue (p < 0.001) compared to the control group
(n = 74), and results remained significant at a 6-month follow
up. This study employed an intensive intervention with weekly
group meetings and “homework” for the participants to prac-
tice individually. Finally, in a 6-month randomized control trial
investigating yoga’s use in MS management, Oken et al. found
that yoga improved levels of fatigue compared to the control
(N = 57, p < 0.001), although the level of improvement was
not significantly different than a conventional aerobic exercise
regimen (Oken et al., 2004).
Other studies have yielded mixed results. In a 2013 study with
24 participants, self-reported measures following a 4-month yoga
intervention indicated improvement in mental components of
QoL (p = 0.01) and fatigue (p = 0.039), but physical com-
ponents of QoL showed no significant change (Salgado et al.,
2013). Participants in this study were in the early stages of MS
and reported low levels of pain both before and after the inter-
vention. In a separate study, a 10-week yoga intervention (Garrett
et al., 2012a,b) had a similar outcome for the mental compo-
nent of the study, but contrary results for the physical compo-
nent. In this study, 63 participants with RRMS, SPMS, or PPMS
and minimal gait impairment reported significant improvement
compared to the control group in the psychological component
of the MS Impact Scale-29 (p = 0.04), Modified Fatigue Impact
Scale (MFIS) total (p = 0.05), and the MFIS physical subscale
(p = 0.04). This intervention focused on relaxation, maintain-
ing poses, and a series of joint freeing exercises to improve range
of motion. Participants showed improvements in all categories
except for gait during a 6-min walk test, although these results
were not maintained at a follow-up 12 weeks later. After the
intervention, participants no longer had access to the instructors,
group exercises, and gym equipment used in the trial and cessa-
tion of exercise may have occurred. Finally, a study with partici-
pants between the ages 26–50, found a 17% increase in selective
attention following the yoga intervention (n = 20, p = 0.015),
although outcomes for mood and fatigue were not significant
(Velikonja et al., 2010). Taken together, these studies indicate
more research is necessary to understand the long-term effects
of yoga for patients with MS.
Physical components of QoL that may be impacted by MS
include spasticity, balance, strength, bladder function, and sex-
ual function. Spasticity, prevalent in up to 80% of MS cases, may
be manifested as muscle stiffness, muscle spasms, or cramping
(Hughes and Howard, 2013). It may also negatively affect pos-
ture, gait, and mobility (Sosnoff and Motl, 2012). Veliknoja et al.
found there was no significant improvement in spasticity follow-
ing a yoga intervention for 20 patients with RRMS or progres-
sive MS (Velikonja et al., 2010). However, because the trial was
uncontrolled, more evidence is needed to examine the effects of
yoga on spasticity. In a study conducted by Guner and Inanici,
they found that a bi-weekly yoga program over the course of 12
weeks yielded significant improvements in balance (p = 0.027),
fatigue (p = 0.012), step length (p = 0.007), and walking speed
(p = 0.005) in a group of eight participants with MS (Guner
and Inanici, 2015). Another study demonstrated a 4-month yoga
intervention yielded improvements with moderate effect sizes in
balance (n = 24, p = 0.002) and functional strength (p <
0.001) following the treatment (Salgado et al., 2013). A 2012 study
tested the efficacy of yoga pelvic floor exercises and breathing
techniques as a complementary method of treating Neurogenic
Bladder Dysfunction (NBD) in 11 patients (Patil et al., 2012).
Ultrasound scanning revealed significantly reduced post void
residual urine volume (p = 0.004), frequency of micturition was
reduced by 25% (p = 0.001), and improvements in self-reported
measures of urogenital distress (p = 0.006) and incontinence
impact (p = 0.003). This was not a randomized control trial,
thus there was no control group. Impaired sexual function and
decreased satisfaction may occur with MS. Additionally, certain
pharmacological therapeutics, such as selective serotonin reup-
take inhibitors, may include sexual dysfunction as a side effect
(DeLuca and Nocentini, 2011). There is evidence suggesting that
yoga may be an effective method for improving sexual function
and physical activity among women with MS (Najafidoulatabad
et al., 2014). A 3-month randomized control trial with a yoga
intervention focusing on slow body movement, respiration, and
concentration, reported participants who received the treatment
reported improved levels of both physical activity and sexual
satisfaction (N = 60, p = 0.001).
Conclusion
Traditionally, healthcare providers advised patients with MS
to limit physical activity in order to reduce levels of fatigue,
although this attitude has shifted due to experimental results
suggesting that exercise is beneficial for patients with MS and
may not adversely affect fatigue (Smith et al., 2013). The litera-
ture suggests there are not only physical benefits of exercise but
also benefits for mental health including neurogenesis, improved
CNS metabolism, and improvements in learning and memory
(Feinstein et al., 2013).
Also, beliefs about the role of CAM therapies and MBI in
MS management have shifted (Simpson et al., 2014). Treatments
such as yoga, cannabinoids, and acupuncture are becoming more
widely endorsed (DeLuca and Nocentini, 2011). Yoga is regarded
as safe, inexpensive, and may be more accessible for patients with
spasticity and impaired mobility than other forms of exercise. A
yoga intervention has been shown to be as beneficial as aerobic
therapy (Oken et al., 2004), and may be more practical for some
MS patients due to readily modifiable poses. In spite of evidence
suggesting that individuals with MS may benefit from yoga as a
complementary therapy, there are inconsistencies and limitations
in experimental results.
A major limitation of studies on yoga and MS is that it is
impossible to blind participants to the intervention, and since
they are aware of the treatment, some may have an expectation
of improvement, which could influence results (Senders et al.,
2012). Additionally, it is difficult to discern whether improve-
ment following interventions may be due to confounding vari-
ables. For instance, some benefits could be conferred through
social interactions during group exercise (Bigi and Yeh, 2013) or
the yoga instructor serving as an encouragingmentor (Kishiyama
et al., 2002). In many studies, participants were assigned to either
a treatment or control group, though evidence supporting the
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outcome is stronger in three-arm trials with an alternate exercise
group that serves as an active control to the yoga intervention
(Senders et al., 2012). Further limitations in previous studies are
frequently small sample sizes and lack of random sampling.
Few studies have addressed the pathophysiology of exercise or
yoga on spasticity in MS. Consequently, little is known about the
possible affect of yoga on this symptom of the disease. Spasticity
is partly due to stretch-induced stimulation in less cooperative
muscles and changes in excitability of motor neurons and spinal
interneurons, which could be impacted by exercise (Sosnoff and
Motl, 2012). However, spasticity is rarely a primary outcome of
interest in existing studies, although it may affect other variables
such as gait and mobility.
There are inconsistencies in the impact of yoga on mental
health. While some studies have shown yoga may reduce stress
and improve mental health (Grossman et al., 2010; Pritchard
et al., 2010), other studies have found no effect. There is cross-
sectional data indicating that exercise is beneficial for cognitive
function in individuals with MS, but there is a lack of ran-
dom control trials with supporting evidence to strengthen these
results (Motl et al., 2011). Depression may be difficult to study
as a variable because some symptoms, such as mental fatigue
and trouble sleeping, may present themselves as depression.
Previous studies have not been rigorous in their methodology
to study this outcome or included clinically depressed partici-
pants in their sample. Some studies may evaluate outcome on
depressedmood, but not have thorough psychological assessment
of depression before and after the intervention (Feinstein et al.,
2013).
Finally, there is little information about how the impact of
yoga may differ between the four courses of MS. Also, inter-
ventions varied in duration between a few weeks to several
months, but little is known about the possible impact of yoga as a
long-term method of symptom management.
Future research needs to employmore thorough study designs
and precise measurements. Since many studies evaluate out-
comes via self-reported measures such as questionnaires and
Likert scales, it is imperative to utilize study designs with suit-
able control groups in order to limit the effect of participant
expectations on outcome. Also, it would be beneficial to use
clinical imaging techniques and precise physical assessment mea-
sures to investigate if quantifiable physical changes correspond to
self-reported measures of improvement.
It is unclear how the frequency, duration, or intensity yoga
practice may impact symptoms experienced by patients. Future
research might investigate whether a certain regimen might be
more effect for improving patient outcome. Also, very few trials
examining yoga andMS have conducted follow up studies. Future
research should include follow up measurements to investigate
if outcomes remained significant or if variables had returned to
their baseline values. Furthermore, longitudinal research should
be done on how yoga may impact symptom management in
the different courses of MS when yoga is incorporated into a
treatment plan from early stages in the disease.
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